2,11,20,29,37,38,39,40-octazanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1(37),2,4(9),5,7,10,12,14,16,18,20,22(27),23,25,28(38),29,31(36),32,34-nonadecaene-6,15,24,33-tetrasulfonic acid

Formula:C32H18N8O12S4 Mutagenic:none Tumorigenic:none Reproductive Effective:none 2,11,20,29,37,38,39,40-octazanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1(37),2,4(9),5,7,10,12,14,16,18,20,22(27),23,25,28(38),29,31(36),32,34-nonadecaene-6,15,24,33-tetrasulfonic acid is not a drug-like molecule.

MolName2,11,20,29,37,38,39,40-octazanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1(37),2,4(9),5,7,10,12,14,16,18,20,22(27),23,25,28(38),29,31(36),32,34-nonadecaene-6,15,24,33-tetrasulfonic acid
MolecularFormulaC32H18N8O12S4
SmilesOS(c1cc2c([nH]3)/N=C(/c(cc4)c5cc4S(O)(=O)=O)\N/C5=N\C(c(cc4)c5cc4S(O)(=O)=O)=N/C5=N\C(c(cc4)c5cc4S(O)(=O)=O)=N/C5=N\c3c2cc1)(=O)=O
InChIInChI=1S/C32H18N8O12S4/c41-53(42,43)13-1-5-17-21(9-13)29-33-25(17)37-30-22-10-14(54(44,45)46)2-6-18(22)27(34-30)39-32-24-12-16(56(50,51)52)4-8-20(24)28(36-32)40-31-23-11-15(55(47,48)49)3-7-19(23)26(35-31)38-29/h1-12H,(H,41,42,43)(H,44,45,46)(H,47,48,49)(H
InChIKNUSQOFAKCBLANB-UHFFFAOYSA-N
TotalMolweight834.803
Molweight834.803
MonoisotopicMass833.992702
CLogP-4.4817
CLogS-3.301
H Acceptors20
H Donors6
TotalSurfaceArea511.71
Relative PSA0.5105
PolarSurfaceArea352.98
Druglikeness0.71254
Mutagenicnone
Tumorigenicnone
Reproductive Effectivenone
Irritanthigh
Nasty Functions
Shape Index0.32143
Fragments1
Non HAtoms56
NonCHAtoms24
Electronegative Atoms24
Rotatable Bond4
Rings Closures9
Small Rings8
Aromatic Rings5
Aromatic Atoms27
Sp3Atoms8
Symmetricatoms4
Aromatic Nitrogens1
BasicNitrogens5
AcidicOxygens4
StereoCon

Request More Details | 2,11,20,29,37,38,39,40-octazanonacyclo[28.6.1.13,10.112,19.121,28.04,9.013,18.022,27.031,36]tetraconta-1(37),2,4(9),5,7,10,12,14,16,18,20,22(27),23,25,28(38),29,31(36),32,34-nonadecaene-6,15,24,33-tetrasulfonic acid


SKU Product Name Product Unit Qty Supplier Email
User Name
User Email
Additional Comments